Ipamorelin's whole reputation rests on one word: selective. That property is genuinely well-documented, but the human evidence behind the compound overall is much thinner than its popularity suggests.
What ipamorelin is
Ipamorelin is a pentapeptide (five amino acids) that acts as a growth hormone secretagogue, activating the ghrelin receptor (GHS-R1a) to stimulate growth hormone release. It was originally developed by Novo Nordisk in the late 1990s.
What's actually been studied
- Selectivity, the foundational finding. The original 1998 characterization established ipamorelin as a potent and selective GH secretagogue, releasing growth hormone without significantly raising cortisol, ACTH, or prolactin, even at doses far above its effective GH-releasing dose (Raun et al., European Journal of Endocrinology, 1998, PubMed).
- Clinical development history. Ipamorelin was investigated clinically for postoperative ileus recovery (helping the gut resume normal function after surgery), and that program did not advance to approval.
Where the evidence is thin
The majority of the evidence establishing ipamorelin's effects, including the foundational selectivity data, comes from animal and in vitro work. Human evidence is limited to a small number of pharmacokinetic and pharmacodynamic studies plus the discontinued postoperative ileus program, not a body of trials establishing outcomes like muscle gain, fat loss, or long-term safety with sustained use in healthy adults. "Selective" is a well-supported mechanistic claim; "proven safe and effective for physique or longevity use" is not the same claim, and isn't what the available data covers.
The regulatory picture
Ipamorelin is not FDA-approved for any use. Its one clinical development program (postoperative ileus) did not result in approval. It's sold by research chemical vendors strictly for laboratory research, not for human use.
Papa's take
I understand why "GH without the cortisol and prolactin spike" is an appealing pitch, and the selectivity data backing that specific claim is real. What's missing is everything downstream of that: outcome data in humans using it the way it's actually discussed online. Mechanism and outcome are different questions, and ipamorelin has decent answers to the first and very little to the second.
Sources
Sourcing for research
If you're sourcing ipamorelin for laboratory research, purity documentation matters. See my vendor comparisons for how I evaluate third-party certificates of analysis.